This we ek in Nature Biotechnology, Broughton et al. (teams from UCSF and Mammoth Bio) publish a CRISPR-based COVID-19 detection method that is "a faster alternative to the CDC PCR assay" at "under 45 minutes" using lateral flow.
- See new 8 page report at Nature Biotech here.
- See the UCSF press release here.
- See Mammoth's press release here.
- Mammoth raised $45M in January 2020 here.
- For a mid-March article on Mammoth and diagnostics at Forbes, here.
- See coverage at Genomeweb here.
* * *